SMO ClinPlus CO.,LTD. (SHE:301257)
China · Delayed Price · Currency is CNY 41.73
+2.05 (5.17%)
At close: Sep 21, 2026
SMO ClinPlus CO.,LTD. Revenue
SMO ClinPlus CO.,LTD. had revenue of 178.34M CNY in the quarter ending June 30, 2026, a decrease of -16.52%. This brings the company's revenue in the last twelve months to 824.77M, up 3.16% year-over-year. In the year 2025, SMO ClinPlus CO.,LTD. had annual revenue of 842.50M with 4.82% growth.
Revenue (ttm)
824.77M
Revenue Growth
+3.16%
P/S Ratio
4.00
Revenue / Employee
179.42K
Employees
4,597
Market Cap
3.30B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 842.50M | 38.78M | 4.82% |
| Dec 31, 2024 | 803.73M | 43.69M | 5.75% |
| Dec 31, 2023 | 760.04M | 173.81M | 29.65% |
| Jan 1, 2023 | 586.23M | 83.27M | 16.55% |
| Dec 31, 2021 | 502.97M | 167.68M | 50.01% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Shanghai Runda Medical Technology | 6.72B |
| Maccura Biotechnology Co.Ltd | 2.13B |
| Medicalsystem Biotechnology | 1.63B |
| Beijing Strong Biotechnologies,Inc. | 1.37B |
| Shanghai Labway Clinical Laboratory | 1.28B |
| Berry Genomics Co.,Ltd | 929.15M |
| Thalys Medical Technology Group | 836.23M |
| Guangdong Hybribio Biotech | 654.72M |